| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.41T | 1.37T | 1.41T | 1.26T | 1.02T |
| Gross Profit | 417.42B | 428.64B | 435.17B | 377.96B | 279.99B |
| EBITDA | 210.80B | 218.84B | 236.15B | 199.53B | 149.00B |
| Net Income | 73.19B | 81.43B | 93.29B | 70.17B | 75.83B |
Balance Sheet | |||||
| Total Assets | 1.86T | 1.79T | 1.84T | 1.66T | 1.44T |
| Cash, Cash Equivalents and Short-Term Investments | 141.46B | 147.14B | 143.53B | 111.99B | 94.26B |
| Total Debt | 568.53B | 610.42B | 649.82B | 579.26B | 414.54B |
| Total Liabilities | 901.65B | 933.05B | 1.02T | 958.20B | 769.48B |
| Stockholders Equity | 900.17B | 809.34B | 763.38B | 659.99B | 611.61B |
Cash Flow | |||||
| Free Cash Flow | 123.25B | 111.58B | 27.31B | -78.97B | 11.39B |
| Operating Cash Flow | 164.22B | 143.93B | 73.03B | -26.14B | 39.32B |
| Investing Cash Flow | -46.73B | -58.05B | -39.63B | -61.67B | -6.85B |
| Financing Cash Flow | -136.32B | -80.16B | -8.32B | 106.11B | -25.61B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥338.57B | 12.19 | ― | 2.99% | 5.65% | 11.14% | |
70 Outperform | ¥3.37T | 15.01 | 7.55% | 2.22% | 5.51% | 12.24% | |
69 Neutral | ¥6.42T | 16.46 | ― | 4.06% | 0.69% | -12.55% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥1.15T | 15.52 | 9.16% | 3.98% | 2.49% | -10.13% | |
52 Neutral | ¥14.24B | 3.08 | ― | 5.40% | 6.43% | ― |